How is Levoleucovorin Intravenous Route dosed?
Levoleucovorin Intravenous Route is available in powder for solution and solution dosage forms. The dosage and route of administration depend on the indication for use. For rescue treatment after high-dose methotrexate treatment in osteosarcoma, the usual dose is 100 mg/m2 intravenously. For reducing toxic effects of folic acid blocker overdose or methotrexate in patients who cannot eliminate this drug properly from their bodies, the usual dose is 5 mg/kg intravenously every 6 hours for 3 doses, or 25 mg/kg intravenously as a single dose. When used together with fluorouracil for metastatic colon or rectal cancer, the dosage and administration depend on the specific regimen and patient characteristics. It is important to follow the doctor's instructions regarding dosage and administration.
What is the dosage form of Levoleucovorin Intravenous Route?
The dosage forms of Levoleucovorin Intravenous Route include Powder for Solution and Solution.
How is Levoleucovorin Intravenous Route administered?
Levoleucovorin Intravenous Route is administered under the direct supervision of a doctor. It can come in the form of a powder for solution or a solution itself. The appropriate dosage form will depend on the medical condition being treated.
What are common precautions when taking Levoleucovorin Intravenous Route?
Common precautions when taking Levoleucovorin Intravenous Route include:
- Allergies: Inform your doctor if you have had any unusual or allergic reactions to this medicine or any other medications.
- Pregnancy: There is not enough information available to determine the safety of Levoleucovorin during pregnancy. Consult your doctor for guidance.
- Breastfeeding: It is not known whether Levoleucovorin can be passed through breast milk. Consult your doctor before using this medication while breastfeeding.
- Liver disease: This medication may need to be used with caution in patients with liver disease.
- Kidney disease: This medication may need to be used with caution in patients with kidney disease.
- Premature infants: The safety and efficacy of Levoleucovorin have not been established in premature infants.
- Children: Safety and efficacy have not been established in children for certain indications.
- Geriatric: This medication is not recommended for use in elderly patients with decreased liver or kidney function. Please note that this information does not replace the advice of a healthcare professional. Consult your doctor for personalized medical advice and guidance.